- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AHA: New Referral Policies Raise Participation by Overcoming Patient, Healthcare-Related Barriers
For patients with cardiovascular disease, participation in cardiac rehabilitation/secondary prevention programs (CR/SPPs) can be enhanced by overcoming patient and health care system-related barriers, and implementing new methods and policies for referral and enrollment, according to an American Heart Association policy statement published online in Circulation.
Gary J. Balady, M.D., from Boston University, and colleagues investigated barriers to referral and enrollment in CR/SPPs, and provided recommendations for enhancing the quality of and participation in CR/SPPs.
"Preventing secondary cardiac events is an essential part of the care for patients with cardiovascular disease," the authors write.
Read more at: http://www.physiciansbriefing.com/Article.asp?AID=658975
Source: HealthDay; American Heart Association
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More
Gestational Diabetes Is a Key Population Health Opportunity
December 7th 2023Diagnosing and treating gestational diabetes can have long-term positive effects on the health of the mother and the baby, warranting a distinct focus on the condition, according to an Institute for Value-Based Medicine® event held in Cleveland, Ohio.
Read More
Refining Precision Prevention for Benign Breast Disease
December 7th 2023Many questions remain surrounding accurately classifying the risk of developing invasive breast cancer associated with the benign breast disease diagnoses of nonproliferative lesions and proliferative changes without atypia.
Read More
Exagamglogene Autotemcel Meets End Points in Severe Sickle Cell Disease, β-Thalassemia
December 7th 2023Two posters set to be presented at the 65th American Society of Hematology Annual Meeting & Exposition met their primary and secondary end points regarding exagamglogene autotemcel therapy for sickle cell disease and β-thalassemia.
Read More
